SINGAPORE · MEDICAL DEVICES

Singapore Post-Market Duties: Adverse Events, FSCA, Annual Retention

On a Friday afternoon a sales representative hears from a hospital nurse that a registered Class C patient monitor failed to alarm the previous week and the patient, treated late, was moved to ICU. He plans to tell the importer on Monday; the importer’s instinct is to wait for the manufacturer’s investigation. Under Singapore’s rules both decisions already put the company at risk: the clock started when the sales representative learned of the event, and the importer, the registrant and the manufacturer each carry their own duty to report.

Singapore’s post-market system does not run on periodic reports; it runs on adverse-event deadlines that start at awareness, a “notify HSA before you act” rule for field safety corrective actions (FSCA) and recalls, and annual payments that keep the registration and the dealer’s licence alive.

The manufacturer has reported. Do the importer and the registrant still have to?

Yes. HSA requires all companies dealing in medical devices, including importers, manufacturers, suppliers and registrants, to report adverse events involving their products, and each dealer involved submits its own report. An event is reportable when an adverse event (or potential adverse event) occurred, the device is associated with it, and the outcome is a serious threat to public health, death, serious deterioration in health, or a risk of death or serious injury if it recurs. HSA’s stated position is a pre-disposition to report in case of doubt.(Source: HSA Report Adverse Events, 2026-03-26)

The legal clock is regulation 42(1) of the Health Products (Medical Devices) Regulations 2010: 48 hours for a serious threat to public health, 10 days for an event that led to death or serious deterioration in health, and 30 days where recurrence might lead to death or serious deterioration.(Source: Health Products (Medical Devices) Regulations 2010, 2010-08-10, reg 42(1))

Events occurring outside Singapore do not have to be reported to HSA even if the same device is supplied in Singapore, unless the registration or licence conditions require it or HSA has issued a notice requesting the information. Forwarding every overseas event to Singapore is therefore not a legal requirement, but the conditions attached to each registration must be checked.(Source: HSA Report Adverse Events, 2026-03-26)

48 hours, 10 days, 30 days: when does the clock start and when is the file closed?

The clock starts when any personnel in the company, including sales representatives, become aware of the event, not when the quality department receives a formal complaint or the manufacturer finishes its investigation. If reportability is unclear, a report is still due within the time frame. A final report describing the investigation follows within 30 days of the initial report; HSA may ask for further follow-up. The form is the Mandatory Medical Device Adverse Event Reporting Form for Medical Device Dealers (MDC-ADE-003), e-mailed to hsa_medical_device@hsa.gov.sg, under 2MB.(Source: HSA Report Adverse Events, 2026-03-26)

Why must HSA be notified before an FSCA or recall starts?

Regulation 46(1) requires notification to HSA before any field safety corrective action is carried out. Regulation 47(1), as amended by S 318/2018 with effect from 1 June 2018, requires a report on the FSCA no later than 21 days after commencement, or a longer period HSA allows; the current text no longer contains a 24-hour preliminary report. Recalls follow regulations 44–45: notification at least 24 hours before the recall and a report within 21 days of commencement or a longer period HSA allows. GN-10 adds that the MDRR1 notification is filed before initiation, a preliminary report is due within 24 hours where HSA requests it, and follow-up or final reports within 21 days; 21 days is not a deadline for closing the investigation.(Source: Health Products (Medical Devices) Regulations 2010, current as at 2026-10-26, regs 44–47; HSA, FSCA: How to report, 2026-03-26)

The scope is wide: an FSCA is reportable if the device was manufactured, imported or supplied in Singapore, or is registered on the SMDR, listed in the Class A database or authorised under a special access route. The reporting party is the dealer that manufactured, imported or supplied the device, or the registrant; several dealers may each need to report. Once HSA is notified the dealer may proceed without waiting for approval.(Source: HSA FSCA: When to report, 2026-03-13)

Operationally, dealers file through OSCAR (CorpPass login) using three forms: MDRR1, the notification and preliminary report, submitted before initiating the FSCA or recovering stock in Singapore, with whatever information is available; MDRR2, the final report; and MDRR3, for devices registered, Class A-listed or SAR-authorised but not yet supplied in Singapore, due within 30 days of initiating the FSCA anywhere in the world. HSA’s MDRR1 acknowledgement sets the standard measure: recall, labelling, supply of correction-in-progress devices allowed, or cease supply.(Source: HSA FSCA: How to report, 2026-03-26)

The duties after notification are equally specific. All consignees are informed through a Field Safety Notice (FSN), a single PDF not marked “Draft”; a Dear Healthcare Professional Letter may be sent only after HSA’s written clearance, as may any consumer-level communication. FSCA records (FSN, affected-consignee list, acknowledgements or service reports) are kept for at least two years from completion or the device’s projected useful life, whichever is longer, and corrected devices need a change notification before supply. Non-compliance with an HSA notice under regulation 46(4) carries a fine of up to S$10,000, up to six months’ imprisonment, or both.(Source: HSA FSCA: Risk management, 2026-03-13)

No periodic report, but how long must records be kept?

Singapore does not require periodic safety update reports, but the Regulations are specific about records. Distribution records are kept for the longer of the device’s projected useful life or two years after supply; complaint records for at least five years after the projected useful life expires. These records are what let a dealer identify affected consignees within hours when an FSCA starts.(Source: Health Products (Medical Devices) Regulations 2010, 2010-08-10, regs 39(2)(b) and 41(2)(b))

The current guidance set is GN-05 R3 (adverse events, September 2023), GN-10 R4 (FSCA, July 2025), GN-04 R2.2 (recall), GN-06 R3 (distribution records, November 2022) and GN-02 R8 (dealer licensing, April 2026).(Source: HSA Medical Devices Guidance Documents, 2026-09-30)

The registration does not expire, so what has to be done every year?

A Singapore product registration has no fixed term; the SMDR listing is kept alive by an annual retention fee, payable under regulation 50(3) on or before each anniversary of registration. HSA’s fee page sets it at S$39 for Class B, S$67 for Class C and S$134 for Class D, with retention completed on successful payment before the deadline.(Source: Health Products (Medical Devices) Regulations 2010, 2010-08-10, reg 50(3); HSA Medical Device Fees, 2026-03-26)

The dealer’s licence (manufacturer, importer or wholesaler) is renewed annually: S$1,110 for a new licence or renewal and S$168 for an amendment, each with a 10-working-day target, and renewal takes effect on payment before the expiry date. Licence holders notify HSA of changes such as device risk class, QMS certification and site details.(Source: HSA Medical Device Fees, 2026-03-26; HSA Dealer’s Licence, 2026-03-13)

For planning, Singapore’s post-market duties combine event-driven obligations with two fixed annual dates. The first needs an internal channel from the field to the person who files, not a wait for the manufacturer’s conclusion; the second depends on who the registrant is and who holds the importer’s licence, which may be different companies. A hypothetical illustration: a Class C device is registered by registrant A and imported and sold by B. When B’s sales representative learns of the event on Friday, A and B each have 10 calendar days to report and 30 days for final reports. If the manufacturer then decides on a global firmware correction, A files MDRR1 before the action starts in Singapore, and B produces the affected-consignee list from its distribution records.